DBV TECHNOLOGIES S A DBVT
SPONSORED ADS · ADR · CUSIP 23306J309
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBagneux, France
- Founded2002
- Websitedbv-technologies.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $16.06.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 19 |
| Q1 2025 | 17 |
| Q2 2025 | 30 |
| Q3 2025 | 33 |
| Q4 2025 | 52 |
| Q1 2026 | 71 |
| Q2 2026 | 78 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 7 | 6 |
| Q2 2025 | 19 | 6 |
| Q3 2025 | 15 | 10 |
| Q4 2025 | 40 | 11 |
| Q1 2026 | 42 | 23 |
| Q2 2026 | 34 | 34 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $0 | $0 | — |
| Q4 2025 | $0 | $0 | — |
| Q1 2026 | $146.2k | $0 | 0.00 |
| Q2 2026 | $0 | $0 | — |
Biggest buyers
| UBS Group AG | Added | +1.2m |
| Logos Global Management LP | New | +915.0k |
| MORGAN STANLEY | Added | +808.8k |
| PERCEPTIVE ADVISORS LLC | Added | +689.0k |
| Patient Square Capital LP | Added | +215.9k |
| JANE STREET GROUP, LLC | Added | +212.6k |
| GREAT POINT PARTNERS LLC | New | +156.9k |
| AMERIPRISE FINANCIAL INC | Added | +147.1k |
| HRT FINANCIAL LP | Added | +127.1k |
| Diversify Advisory Services, LLC | New | +89.7k |
Biggest sellers
| MPM BIOIMPACT LLC | Reduced | -1.5m |
| Artisan Partners Limited Partnership | Reduced | -846.5k |
| Vivo Capital, LLC | Reduced | -822.8k |
| ADAR1 Capital Management, LLC | Reduced | -484.6k |
| Atika Capital Management LLC | Sold out | -271.3k |
| Balyasny Asset Management L.P. | Sold out | -233.4k |
| Redmile Group, LLC | Reduced | -80.9k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -51.2k |
| NEW YORK STATE COMMON RETIREMENT FUND | Reduced | -48.8k |
| Russell Investments Group, Ltd. | Reduced | -44.4k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BAKER BROS. ADVISORS LP
13D · may seek influence
-7.1 pts · filed 2026-01-14
Stated purposeItem 4 of Schedule 13D is supplemented and amended, as the case may be, as follows: On January 12, 2026, 667 and Life Sciences exercised 2,299,656 and 25,005,240 warrants, respectively, (each, a "BS Warrant") of the Issuer, at a strike price of EUR 1.5764, on a one-for-one basis into pre-funded warrants (each, a "Second Pre-Funded Warrant"), each of which are exercisable for 1.75 Ordinary Shares of the Issuer at an exercise price of EUR 0.0175. The BS Warrants were exercisable until January 15, 2026, which is 30 days following the publication by the Issuer that the VITESSE Phase 3 study met its primary endpoint as further described in the Terms and Conditions of the BS Warrants. Each of the Funds paid the exercise price for the BS Warrants using its working capital. The Second Pre-Funded… Full filing |
10.0% |
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor new · filed 2025-04-11 | 9.9% |
| JANUS HENDERSON GROUP PLC 13G · institution +6.2 pts · filed 2026-01-08 | 8.8% |
| Adage Capital Management, L.P. 13G · institution -2.7 pts · filed 2026-05-13 | 7.3% |
| Invus Global Management, LLC 13G · passive investor +0.3 pts · filed 2026-05-05 | 6.5% |
| CITADEL ADVISORS LLC 13G · passive investor new · filed 2025-04-14 | 6.4% |
| MPM BioImpact LLC 13G · institution -2.6 pts · filed 2026-08-14 | 6.2% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor new · filed 2026-08-06 | 5.8% |
Fell to 5% or below in the last year: Artisan Partners Limited Partnership (3.7%, 2026-05-13), Vivo Opportunity Fund Holdings, L.P. (4.0%, 2026-05-12), Venrock Healthcare Capital Partners II, L.P. (0.0%, 2026-02-17), Bpifrance Participations SA (4.7%, 2026-01-07)
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2024 | 0 | — | 1 | — | — |
| Q1 2025 | 0 | — | 1 | — | — |
| Q2 2025 | 0 | — | 1 | $730 | — |
| Q3 2025 | 0 | — | 1 | — | — |
| Q4 2025 | 0 | — | 1 | — | — |
| Q1 2026 | 0 | — | 1 | $2.6k | — |
| Q2 2026 | 0 | — | 0 | — | — |
| Q3 2026 | 0 | — | 1 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2026-07-29 | Mohideen Pharis Chief Medical Officer | Sold | —464 shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| MPM BIOIMPACT LLC 3.67% of their portfolio | 3.7m $60.1m | Reduced -1.5m |
| Siren, L.L.C. 0.62% of their portfolio | 1.9m $30.5m | Unchanged |
| Vivo Capital, LLC 2.76% of their portfolio | 1.8m $30.3m | Reduced -822.8k |
| PERCEPTIVE ADVISORS LLC 0.42% of their portfolio | 1.7m $27.1m | Added +689.0k |
| BAKER BROS. ADVISORS LP 0.12% of their portfolio | 1.5m $24.0m | Unchanged |
| Artisan Partners Limited Partnership 0.04% of their portfolio | 1.4m $22.5m | Reduced -846.5k |
| UBS Group AG 0.00% of their portfolio | 1.3m $21.5m | Added +1.2m |
| MORGAN STANLEY 0.00% of their portfolio | 954.9k $15.7m | Added +808.8k |
| Logos Global Management LP 0.65% of their portfolio | 915.0k $15.0m | New |
| Patient Square Capital LP 2.31% of their portfolio | 909.5k $14.9m | Added +215.9k |
| Octagon Capital Advisors LP 0.86% of their portfolio | 574.2k $9.4m | Unchanged |
| ADAR1 Capital Management, LLC 0.41% of their portfolio | 528.3k $8.7m | Reduced -484.6k |
| Ikarian Capital, LLC 0.28% of their portfolio | 525.0k $1.7m | Unchanged |
| Redmile Group, LLC 0.45% of their portfolio | 410.4k $6.7m | Reduced -80.9k |
| Duquesne Family Office LLC 0.14% of their portfolio | 383.4k $6.3m | Unchanged |
| AMERIPRISE FINANCIAL INC 0.00% of their portfolio | 378.5k $6.2m | Added +147.1k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 267.8k $4.4m | Reduced -51.2k |
| Elmind Capital, LP 1.09% of their portfolio | 265.0k $4.3m | Unchanged |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 223.9k $3.7m | Added +212.6k |
| Ishara Investments LP 2.22% of their portfolio | 184.5k $3.0m | Added +82.0k |
| Yiheng Capital Management, L.P. 1.23% of their portfolio | 170.1k $2.8m | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC 0.05% of their portfolio | 163.4k $2.7m | Unchanged |
| GREAT POINT PARTNERS LLC 0.61% of their portfolio | 156.9k $2.6m | New |
| HRT FINANCIAL LP 0.01% of their portfolio | 151.2k $2.5m | Added +127.1k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 119.3k $2.0m | Reduced -48.8k |
| ENVESTNET ASSET MANAGEMENT INC 0.00% of their portfolio | 113.8k $1.9m | Added +18.1k |
| XTX Topco Ltd 0.02% of their portfolio | 91.2k $1.5m | Added +49.1k |
| Diversify Advisory Services, LLC 0.02% of their portfolio | 89.7k $1.2m | New |
| DIVERSIFY WEALTH MANAGEMENT, LLC 0.02% of their portfolio | 89.7k $1.2m | Added +26.0k |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 84.2k $1.4m | Reduced -44.4k |
| Dorsey Wright & Associates 0.20% of their portfolio | 73.1k $1.2m | Reduced -29.4k |
| Polymer Capital Management (HK) LTD 0.11% of their portfolio | 64.5k $1.1m | Unchanged |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 59.2k $971.5k | New |
| LPL Financial LLC 0.00% of their portfolio | 53.8k $881.5k | Reduced -2.1k |
| AdvisorShares Investments LLC 0.09% of their portfolio | 43.7k $716.1k | Reduced -6.7k |
| Cetera Investment Advisers 0.00% of their portfolio | 35.3k $578.2k | Added +9.9k |
| Engineers Gate Manager LP 0.01% of their portfolio | 32.4k $532.0k | Reduced -601 |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 28.8k $472.4k | Reduced -8.6k |
| STIFEL FINANCIAL CORP 0.00% of their portfolio | 27.6k $452.8k | Reduced -3.1k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 22.8k $373.6k | New |
| Burns Matteson Capital Management, LLC 0.11% of their portfolio | 21.8k $357.8k | Reduced -813 |
| Atria Investments, Inc 0.00% of their portfolio | 18.9k $310.0k | Reduced -2.2k |
| Persistent Asset Partners Ltd 0.08% of their portfolio | 15.6k $256.3k | Added +4.2k |
| PERSONAL CFO SOLUTIONS, LLC 0.03% of their portfolio | 12.9k $212.2k | Added +297 |
| Point72 Asset Management, L.P. 0.00% of their portfolio | 12.1k $199.2k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 11.6k $190.7k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 11.6k $189.8k | New |
| SEI INVESTMENTS CO 0.00% of their portfolio | 10.8k $177.3k | Reduced -6.0k |
| Integrated Wealth Concepts LLC 0.00% of their portfolio | 10.4k $170.1k | Reduced -213 |
| China Universal Asset Management Co., Ltd. 0.01% of their portfolio | 8.0k $131.2k | Added +3.0k |
| BARCLAYS PLC 0.00% of their portfolio | 7.2k $118.0k | Reduced -881 |
| Optiver Holding B.V. 0.00% of their portfolio | 6.5k $105.9k | Reduced -12.6k |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 5.6k $92.0k | Reduced -488 |
| Truvestments Capital LLC 0.01% of their portfolio | 3.9k $63.8k | Unchanged |
| GAMMA Investing LLC 0.00% of their portfolio | 2.8k $46.4k | Reduced -67 |
| Allworth Financial LP 0.00% of their portfolio | 1.7k $27.6k | Unchanged |
| State of Wyoming 0.00% of their portfolio | 1.4k $23.7k | New |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 1.2k $20.4k | New |
| HM PAYSON & CO 0.00% of their portfolio | 420 $6.9k | Unchanged |
| Continuum Advisory, LLC 0.00% of their portfolio | 400 $6.6k | New |
| HARBOUR INVESTMENTS, INC. 0.00% of their portfolio | 362 $5.9k | Added +103 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 300 $4.9k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 277 $4.5k | Reduced -844 |
| Wilmington Savings Fund Society, FSB 0.00% of their portfolio | 276 $4.5k | New |
| Ascentis Wealth Management, LLC 0.00% of their portfolio | 259 $4.2k | Unchanged |
| NISA INVESTMENT ADVISORS, LLC 0.00% of their portfolio | 200 $3.3k | New |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 164 $2.7k | Unchanged |
| Federation des caisses Desjardins du Quebec 0.00% of their portfolio | 145 $2.4k | Unchanged |
| Silver Grove Financial Group, Inc. 0.00% of their portfolio | 81 $1.3k | New |
| Larson Financial Group LLC 0.00% of their portfolio | 66 $1.1k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 53 $848 | Added +33 |
| Pinnacle Wealth Planning Services, Inc. 0.00% of their portfolio | 40 $656 | Unchanged |
| NATIONAL BANK OF CANADA /FI/ 0.00% of their portfolio | 23 $371 | New |
| Bell Investment Advisors, Inc 0.00% of their portfolio | 21 $345 | Unchanged |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 13 $213 | Reduced -54 |
| TRUST CO OF TOLEDO NA /OH/ 0.00% of their portfolio | 10 $164 | Unchanged |
| Stone House Investment Management, LLC 0.00% of their portfolio | 9 $148 | New |
| BlackRock, Inc. 0.00% of their portfolio | 2 $33 | Unchanged |